Cookson Peirce & Co’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$862K Buy
7,810
+1,597
+26% +$154K 0.03% 218
2026
Q2
$486K Buy
+6,213
New +$424K 0.02% 258
2024
Q4
– Sell
-315,378
Closed -$18.1M – 283
2024
Q3
$18.1M Buy
+315,378
New +$18.1M 0.85% 40
2023
Q1
– Sell
-46,272
Closed -$2.63M – 233
2022
Q4
$2.63M Sell
46,272
-4,659
-9% -$239K 0.17% 70
2022
Q3
$2.01M Buy
50,931
+629
+1% +$27.8K 0.14% 83
2022
Q2
$2.21M Buy
+50,302
New +$2.18M 0.15% 82

Other funds holding HALO

Cookson Peirce & Co's HALO Position: Q3 2026 in Review

Cookson Peirce & Co increased its Halozyme (HALO) stake by 26% in Q3 2026, buying an estimated $154K and bringing the position to 7,810 shares worth $862K. The position accounts for 0.03% of the portfolio, ranked #218.

Cookson Peirce & Co first reported a position in HALO in Q2 2022 and has held it in 6 quarters since. The position peaked at $18.1M in Q3 2024. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Cookson Peirce & Co held 7,810 shares of Halozyme worth $862K as of Q3 2026.
  • Cookson Peirce & Co bought 1,597 Halozyme shares in Q3 2026, an estimated $154K.
  • Halozyme made up 0.03% of Cookson Peirce & Co's portfolio in Q3 2026, its #218 holding.
  • Cookson Peirce & Co first reported a position in Halozyme in Q2 2022 and has held it in 6 quarters since.
  • Cookson Peirce & Co's Halozyme position peaked at $18.1M in Q3 2024.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.